| 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task … DK Arnett, RS Blumenthal, MA Albert, AB Buroker, ZD Goldberger, ... Journal of the American College of Cardiology 74 (10), 1376-1414, 2019 | 2051 | 2019 |
| A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly S Wongrakpanich, A Wongrakpanich, K Melhado, J Rangaswami Aging and disease 9 (1), 143, 2018 | 1029 | 2018 |
| Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association J Rangaswami, V Bhalla, JEA Blair, TI Chang, S Costa, KL Lentine, ... Circulation 139 (16), e840-e878, 2019 | 984 | 2019 |
| Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association CE Ndumele, J Rangaswami, SL Chow, IJ Neeland, KR Tuttle, SS Khan, ... Circulation 148 (20), 1606-1635, 2023 | 331 | 2023 |
| American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology. Cardiorenal syndrome: classification, pathophysiology, diagnosis … J Rangaswami, V Bhalla, JEA Blair, TI Chang, S Costa, KL Lentine, ... Circulation 139 (16), e840-e878, 2019 | 216 | 2019 |
| A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association CE Ndumele, IJ Neeland, KR Tuttle, SL Chow, RO Mathew, SS Khan, ... Circulation 148 (20), 1636-1664, 2023 | 195 | 2023 |
| Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies J Rangaswami, RO Mathew, R Parasuraman, E Tantisattamo, M Lubetzky, ... Nephrology Dialysis Transplantation 34 (5), 760-773, 2019 | 191 | 2019 |
| Development and validation of the American Heart Association’s PREVENT equations SS Khan, K Matsushita, Y Sang, SH Ballew, ME Grams, A Surapaneni, ... Circulation 149 (6), 430-449, 2024 | 175 | 2024 |
| Class effects of SGLT2 inhibitors on cardiorenal outcomes AY Kluger Textbook of Cardiorenal Medicine, 279-294, 2021 | 167 | 2021 |
| Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the … SS Khan, J Coresh, MJ Pencina, CE Ndumele, J Rangaswami, SL Chow, ... Circulation 148 (24), 1982-2004, 2023 | 164 | 2023 |
| Cardiorenal protection with the newer antidiabetic agents in patients with diabetes and chronic kidney disease: a scientific statement from the American Heart Association J Rangaswami, V Bhalla, IH De Boer, A Staruschenko, JA Sharp, ... Circulation 142 (17), e265-e286, 2020 | 158 | 2020 |
| Anticoagulation and bleeding risk in patients with COVID-19 N Musoke, KB Lo, J Albano, E Peterson, R Bhargav, F Gul, R DeJoy III, ... Thrombosis research 196, 227-230, 2020 | 137 | 2020 |
| Anticoagulation‐related nephropathy DS Wheeler, RP Giugliano, J Rangaswami Journal of Thrombosis and Haemostasis 14 (3), 461-467, 2016 | 137 | 2016 |
| A review of nutritional factors in hypertension management H Nguyen, OA Odelola, J Rangaswami, A Amanullah International journal of hypertension 2013 (1), 698940, 2013 | 132 | 2013 |
| Bacterial infections and patterns of antibiotic use in patients with COVID‐19 A Goncalves Mendes Neto, KB Lo, A Wattoo, G Salacup, J Pelayo, ... Journal of medical virology 93 (3), 1489-1495, 2021 | 129 | 2021 |
| The effects of SGLT2 inhibitors on cardiovascular and renal outcomes in diabetic patients: a systematic review and meta-analysis KB Lo, F Gul, P Ram, AY Kluger, KM Tecson, PA McCullough, ... Cardiorenal medicine 10 (1), 1-10, 2020 | 123 | 2020 |
| Clinical characteristics and outcomes of community-and hospital-acquired acute kidney injury with COVID-19 in a US inner city hospital system J Pelayo, KB Lo, R Bhargav, F Gul, E Peterson, R DeJoy III, GF Salacup, ... Cardiorenal medicine 10 (4), 223-231, 2020 | 90 | 2020 |
| Carcinoid heart disease: review of current knowledge P Ram, JL Penalver, KBU Lo, J Rangaswami, GS Pressman Texas Heart Institute Journal 46 (1), 21-27, 2019 | 82 | 2019 |
| Hyponatremia in heart failure: pathogenesis and management M Rodriguez, M Hernandez, W Cheungpasitporn, KB Kashani, I Riaz, ... Current cardiology reviews 15 (4), 252-261, 2019 | 79 | 2019 |
| Cardiorenal Outcomes in the CANVAS, DECLARE-TIMI 58, and EMPA-REG OUTCOME Trials: A Systematic Review. AY Kluger, KM Tecson, CM Barbin, AY Lee, EV Lerma, ZP Rosol, ... Reviews in cardiovascular medicine 19 (2), 2018 | 79 | 2018 |
Kevin Bryan LoBrigham and Women’s HospitalEmail verificata su bwh.harvard.edu